#$%^&*AU2011101624A420120119.pdf#####ABSTRACT A method is provided for administering to a mammal suffering from, or at risk for, an intraocular neovascular disorder with regular dosing of a therapeutically effective amount of VEGF antagonist, followed by less frequent dosing of a therapeutically s effective amount of VEGF antagonist. 301061_1 (GHMttes) P71763 AU2 0-0DooII